Home / Publications / Molecular modelling of central nervous system receptors

Molecular modelling of central nervous system receptors

Nikolai Serafimovich Zefirov 1
Nikolai Serafimovich Zefirov
, 
Vladimir Alexandrovich Palyulin 1
Vladimir Alexandrovich Palyulin
10.1016/j.mencom.2010.09.001
Published 2010-09-09
Focus article , Volume 20, Issue 5, 243-248
3
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Zefirov N. S., Palyulin V. A. Molecular modelling of central nervous system receptors // Mendeleev Communications. 2010. Vol. 20. No. 5. pp. 243-248.
GOST all authors (up to 50) Copy
Zefirov N. S., Palyulin V. A. Molecular modelling of central nervous system receptors // Mendeleev Communications. 2010. Vol. 20. No. 5. pp. 243-248.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2010.09.001
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2010.09.001
TI - Molecular modelling of central nervous system receptors
T2 - Mendeleev Communications
AU - Zefirov, Nikolai Serafimovich
AU - Palyulin, Vladimir Alexandrovich
PY - 2010
DA - 2010/09/09
PB - Mendeleev Communications
SP - 243-248
IS - 5
VL - 20
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2010_Zefirov,
author = {Nikolai Serafimovich Zefirov and Vladimir Alexandrovich Palyulin},
title = {Molecular modelling of central nervous system receptors},
journal = {Mendeleev Communications},
year = {2010},
volume = {20},
publisher = {Mendeleev Communications},
month = {Sep},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2010.09.001},
number = {5},
pages = {243--248},
doi = {10.1016/j.mencom.2010.09.001}
}
MLA
Cite this
MLA Copy
Zefirov, Nikolai Serafimovich, and Vladimir Alexandrovich Palyulin. “Molecular modelling of central nervous system receptors.” Mendeleev Communications, vol. 20, no. 5, Sep. 2010, pp. 243-248. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2010.09.001.
Views / Downloads
1 / 4

Abstract

The molecular models of ionotropic and metabotropic glutamate receptors, ionotropic γ-aminobutyric acid receptors, adenosine and melatonin receptors are discussed; the developed models were used in the design of new neuroprotective compounds.

References

2.
Parsons C.G., Danysz W., Quack G.
Drug News & Perspectives, 2005
4.
Neuroprotective and Cognition-Enhancing Properties of MK-801 Flexible Analogs
BACHURIN S., TKACHENKO S., BASKIN I., LERMONTOVA N., MUKHINA T., PETROVA L., USTINOV A., PROSHIN A., GRIGORIEV V., LUKOYANOV N., PALYULIN V., ZEFIROV N.
Annals of the New York Academy of Sciences, 2006
5.
The structure of the potassium channel: molecular basis of K+ conduction and selectivity.
Doyle D.A., Cabral J.M., Pfuetzner R.A., Kuo A., Gulbis J.M., Cohen S.L., Chait B.T., MacKinnon R.
Science, 1998
6.
3D-Model of the Ion Channel of NMDA Receptor: Qualitative and Quantitative Modeling of the Blocker Binding
Tikhonova I.G., Baskin I.I., Palyulin V.A., Zefirov N.S.
Doklady Biochemistry and Biophysics, 2004
7.
Channel Blockers Acting atN-Methyl-d-aspartate Receptors: Differential Effects of Mutations in the Vestibule and Ion Channel Pore
Kashiwagi K., Masuko T., Nguyen C.D., Kuno T., Tanaka I., Igarashi K., Williams K.
Molecular Pharmacology, 2002
8.
Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones
Mayer M.L., Westbrook G.L., Guthrie P.B.
Nature, 1984
10.
Computer Simulation of the Three-Dimensional Structure of the Glutamate Site of the NR2B Subunit of the NMDA Receptor
Tikhonova I.G., Baskin I.I., Palyulin V.A., Zefirov N.S.
Doklady Biochemistry and Biophysics, 2002
11.
Structural Basis for Understanding Structure−Activity Relationships for the Glutamate Binding Site of the NMDA Receptor
Tikhonova I.G., Baskin I.I., Palyulin V.A., Zefirov N.S., Bachurin S.O.
Journal of Medicinal Chemistry, 2002
12.
Structural Basis for Understanding Structure−Activity Relationships for the Glutamate Binding Site of the NMDA Receptor.
Tikhonova I.G., Baskin I.I., Palyulin V.A., Zefirov N.S., Bachurin S.O.
Journal of Medicinal Chemistry, 2002
14.
10.1016/j.mencom.2010.09.001_bib0065
Tikhonova
Dokl. Akad. Nauk, 2002
15.
CoMFA and Homology-Based Models of the Glycine Binding Site of N-Methyl-d-aspartate Receptor
Tikhonova I.G., Baskin I.I., Palyulin V.A., Zefirov N.S.
Journal of Medicinal Chemistry, 2003
17.
Selectivity Fields:  Comparative Molecular Field Analysis (CoMFA) of the Glycine/NMDA and AMPA Receptors
Baskin I.I., Tikhonova I.G., Palyulin V.A., Zefirov N.S.
Journal of Medicinal Chemistry, 2003
18.
10.1016/j.mencom.2010.09.001_bib0085
Tikhonova
Dokl. Akad. Nauk, 2004
19.
Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor
Kunishima N., Shimada Y., Tsuji Y., Sato T., Yamamoto M., Kumasaka T., Nakanishi S., Jingami H., Morikawa K.
Nature, 2000
20.
10.1016/j.mencom.2010.09.001_bib0095
Tikhonova
Dokl. Akad. Nauk, 2003
21.
10.1016/j.mencom.2010.09.001_bib0100
Tikhonova
Izv. Akad. Nauk, Ser. Khim., 2004
22.
Modeling of Glutamate GluR6 Receptor and Its Interactions with Novel Noncompetitive Antagonists
Kaczor A.A., Kijkowska-Murak U.A., Kronbach C., Unverferth K., Matosiuk D.
Journal of Chemical Information and Modeling, 2009
24.
10.1016/j.mencom.2010.09.001_bib0115
Tikhonova
Dokl. Akad. Nauk, 2004
25.
S. O. Bachurin, V. V. Grigor’ev, N. S. Zefirov, M. I. Lavrov, V. L. Lapteva and V. A. Palyulin, RF Patent RU 2333211, 2008.
27.
10.1016/j.mencom.2010.09.001_bib0130
Baskin
Dokl. Akad. Nauk, 2000
28.
The role of Arg78 in the metabotropic glutamate receptor mGlu1 for agonist binding and selectivity
Jensen A.A., Sheppard P.O., O'Hara P.J., Krogsgaard-Larsen P., Bräuner-Osborne H.
European Journal of Pharmacology, 2000
29.
10.1016/j.mencom.2010.09.001_bib0140
Belenikin
Dokl. Akad. Nauk, 2002
30.
10.1016/j.mencom.2010.09.001_bib0145
Belenikin
Dokl. Akad. Nauk, 2002
31.
10.1016/j.mencom.2010.09.001_bib0150
Belenikin
Dokl. Akad. Nauk, 2002
32.
M. S. Belenikin, A. Macciarulo, G. Costantino, V. A. Palyulin, R. Pellicciari and N. S. Zefirov, Vestn. Mosk. Univ., Ser. 2: Khim., 2002, 43, 221.(in Russian).
33.
10.1016/j.mencom.2010.09.001_bib0160
Belenikin
Dokl. Akad. Nauk, 2003
34.
10.1016/j.mencom.2010.09.001_bib0165
Belenikin
Dokl. Akad. Nauk, 2004
35.
ACTIONS OF ADENOSINE AT ITS RECEPTORS IN THE CNS: Insights from Knockouts and Drugs
Fredholm B.B., Chen J., Masino S.A., Vaugeois J.
Annual Review of Pharmacology and Toxicology, 2005
36.
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm B.B., IJzerman A.P., Jacobson K.A., Klotz K., Linden J.
Pharmacological Reviews, 2001
38.
Ivanov A.A., Baskin I.I., Palyulin V.A., Baraldi P.G., Zefirov N.S.
Mendeleev Communications, 2002
39.
Molecular Modeling and Molecular Dynamics Simulation of the Human A2B Adenosine Receptor. The Study of the Possible Binding Modes of the A2B Receptor Antagonists
Ivanov A.A., Baskin I.I., Palyulin V.A., Piccagli L., Baraldi P.G., Zefirov N.S.
Journal of Medicinal Chemistry, 2005
40.
10.1016/j.mencom.2010.09.001_bib0195
Palyulin
urinergic Signalling, 2006
41.
10.1016/j.mencom.2010.09.001_bib0200
Ivanov
Dokl. Akad. Nauk, 2002
42.
10.1016/j.mencom.2010.09.001_bib0205
Ivanov
Dokl. Akad. Nauk, 2003
43.
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola V., Griffith M.T., Hanson M.A., Cherezov V., Chien E.Y., Lane J.R., IJzerman A.P., Stevens R.C.
Science, 2008
45.
Modeling the Adenosine Receptors:  Comparison of the Binding Domains of A2A Agonists and Antagonists
Kim S., Gao Z., Van Rompaey P., Gross A.S., Chen A., Van Calenbergh S., Jacobson K.A.
Journal of Medicinal Chemistry, 2003
47.
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
Jockers R., Maurice P., Boutin J.A., Delagrange P.
British Journal of Pharmacology, 2008
48.
10.1016/j.mencom.2010.09.001_bib0235
Ivanov
Dokl. Akad. Nauk, 2004
49.
Molecular Modeling Study of the Mechanism of Ligand Binding to Human Melatonin Receptors
Voronkov A.E., Ivanov A.A., Baskin I.I., Palyulin V.A., Zefirov N.S.
Doklady Biochemistry and Biophysics, 2005
50.
Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding
Mazna P., Obsilova V., Jelinkova I., Balik A., Berka K., Sovova Z., Ettrich R., Svoboda P., Obsil T., Teisinger J.
Journal of Neurochemistry, 2004
51.
ERRATUM: Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding
Mazna P., Obsilova V., Jelinkova I., Balik A., Berka K., Sovova Z., Ettrich R., Svoboda P., Obsil T., Teisinger J.
Journal of Neurochemistry, 2004
52.
Rivara S., Mor M., Lorenzi S., Lodola A., Spadoni P.V., Bedini A., Tarzia G.
Arkivoc, 2006
54.
Homology modeling of MT1 and MT2 receptors
Farce A., Chugunov A.O., Logé C., Sabaouni A., Yous S., Dilly S., Renault N., Vergoten G., Efremov R.G., Lesieur D.
European Journal of Medicinal Chemistry, 2008
55.
10.1016/j.mencom.2010.09.001_bib0265
Baranova
Zh. Org. Khim., 2007
56.
GABAAReceptors: Properties and Trafficking
Michels G., Moss S.J.
Critical Reviews in Biochemistry and Molecular Biology, 2007
57.
GABA-Activated Ligand Gated Ion Channels:  Medicinal Chemistry and Molecular Biology
Chebib M., Johnston G.A.
Journal of Medicinal Chemistry, 2000
58.
GABAC RECEPTOR ION CHANNELS
Chebib M.
Clinical and Experimental Pharmacology and Physiology, 2004
59.
The complexity of the GABAA receptor shapes unique pharmacological profiles
D’Hulst C., Atack J.R., Kooy R.F.
Drug Discovery Today, 2009
60.
10.1016/j.mencom.2010.09.001_bib0290
Chupakhin
Dokl. Akad. Nauk, 2006
61.
10.1016/j.mencom.2010.09.001_bib0295
Osolodkin
Dokl. Akad. Nauk, 2007
62.
Molecular modeling of ligand–receptor interactions in GABAC receptor
Osolodkin D.I., Chupakhin V.I., Palyulin V.A., Zefirov N.S.
Journal of Molecular Graphics and Modelling, 2009
63.
V. I. Chupakhin, PhD Thesis, M. V. Lomonosov Moscow State University, 2010.
64.
Anxiety over GABAA receptor structure relieved by AChBP
Cromer B.A., Morton C.J., Parker M.W.
Trends in Biochemical Sciences, 2002
65.
Comparative modeling of GABAA receptors: limits, insights, future developments
Ernst M., Brauchart D., Boresch S., Sieghart W.
Neuroscience, 2003
67.
10.1016/j.mencom.2010.09.001_bib0325
Padgett
J. Neurosci., 2007
68.
Exploring ligand recognition and ion flow in comparative models of the human GABA type A receptor
Mokrab Y., Bavro V.N., Mizuguchi K., Todorov N.P., Martin I.L., Dunn S.M., Chan S.L., Chau P.-.
Journal of Molecular Graphics and Modelling, 2007
69.
Molecular modelling of specific and non-specific anaesthetic interactions
Trudell J.R., Bertaccini E.
British Journal of Anaesthesia, 2002
70.
Molecular modelling of the GABAA ion channel protein
Campagna-Slater V., Weaver D.F.
Journal of Molecular Graphics and Modelling, 2007
71.
Homology Model of the GABAA Receptor Examined Using Brownian Dynamics
O’Mara M., Cromer B., Parker M., Chung S.
Biophysical Journal, 2005
72.
Mapping the ρ1 GABAC Receptor Agonist Binding Pocket
Sedelnikova A., Smith C.D., Zakharkin S.O., Davis D., Weiss D.S., Chang Y.
Journal of Biological Chemistry, 2005
73.
Molecular modeling of the GABAC receptor ligand-binding domain
Harrison N.J., Lummis S.C.
Journal of Molecular Modeling, 2005
74.
A Molecular Basis for Agonist and Antagonist Actions at GABACReceptors
Abdel-Halim H., Hanrahan J.R., Hibbs D.E., Johnston G.A., Chebib M.
Chemical Biology and Drug Design, 2008
75.
Computer-aided design of selective ligands of the benzodiazepine-binding site of the GABAA receptor
Chupakhin V.I., Bobrov S.V., Radchenko E.V., Palyulin V.A., Zefirov N.S.
Doklady Chemistry, 2008
77.
Molecular Field Topology Analysis Method in QSAR Studies of Organic Compounds
Palyulin V.A., Radchenko E.V., Zefirov N.S.
Journal of Chemical Information and Computer Sciences, 2000
78.
E. V. Radchenko, V. A. Palyulin and N. S. Zefirov, Zh. Khim. Ob-va im. D. I. Mendeleeva (Ross. Khim. Zh.), 2006, 50 (2), 76.(in Russian).